News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
182,183 Results
Type
Article (17536)
Company Profile (120)
Press Release (164527)
Section
Business (58220)
Career Advice (941)
Deals (9363)
Drug Delivery (36)
Drug Development (23422)
Employer Resources (70)
FDA (2349)
Job Trends (4241)
News (92230)
Policy (5789)
Tag
Academia (483)
Alliances (16206)
Alzheimer's disease (419)
Antibody-drug conjugate (ADC) (70)
Approvals (2315)
Artificial intelligence (88)
Bankruptcy (84)
Best Places to Work (2896)
Biotechnology (111)
Breast cancer (76)
Cancer (696)
Career advice (756)
CAR-T (80)
Cell therapy (232)
Clinical research (18490)
Collaboration (363)
Compensation (80)
COVID-19 (742)
C-suite (108)
Data (587)
Diabetes (55)
Diagnostics (1067)
Drug discovery (54)
Earnings (15712)
Employer resources (68)
Events (31077)
Executive appointments (314)
FDA (2593)
Funding (307)
Gene therapy (156)
GLP-1 (255)
Government (621)
Healthcare (2388)
Immunology and inflammation (52)
Infectious disease (791)
Inflammatory bowel disease (63)
Interviews (137)
IPO (4104)
Job creations (1478)
Job search strategy (701)
Layoffs (158)
Legal (1185)
Lung cancer (82)
Lymphoma (50)
Manufacturing (124)
Medical device (685)
Medtech (686)
Mergers & acquisitions (5432)
Metabolic disorders (197)
Neuroscience (606)
NextGen: Class of 2025 (1443)
Non-profit (452)
Northern California (763)
Obesity (109)
Opinion (171)
Patents (60)
People (22034)
Phase I (7192)
Phase II (8829)
Phase III (4962)
Pipeline (323)
Postmarket research (306)
Preclinical (2909)
Press Release (61)
Radiopharmaceuticals (81)
Rare diseases (154)
Real estate (2439)
Regulatory (4455)
Research institute (515)
Resumes & cover letters (152)
Series A (74)
Southern California (716)
Startups (1779)
United States (6407)
Vaccines (206)
Weight loss (80)
Date
Today (4)
Last 7 days (219)
Last 30 days (991)
Last 365 days (12521)
2025 (1718)
2024 (12666)
2023 (13202)
2022 (16044)
2021 (16931)
2020 (13184)
2019 (9503)
2018 (7544)
2017 (8978)
2016 (8114)
2015 (9409)
2014 (9727)
2013 (9450)
2012 (6081)
2011 (6461)
2010 (5852)
Location
Africa (324)
Asia (13403)
Australia (2667)
California (1793)
Canada (627)
China (161)
Connecticut (74)
Europe (30003)
Florida (194)
Illinois (121)
Indiana (95)
Maryland (275)
Massachusetts (1417)
Michigan (88)
Minnesota (105)
New Jersey (478)
New York (456)
North Carolina (319)
Northern California (763)
Pennsylvania (383)
South America (400)
Southern California (716)
Texas (206)
Washington State (299)
182,183 Results for "portage biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Portage Biotech Announces Completion of $2.15 Million Private Financing
January 30, 2025
·
2 min read
Press Releases
Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
February 13, 2025
·
2 min read
Press Releases
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
December 18, 2024
·
4 min read
Press Releases
Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company
January 6, 2025
·
4 min read
Press Releases
Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024
November 27, 2024
·
10 min read
Pharm Country
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
Portage Biotech Inc. reported that it has completed selling its equity holding in Intensity Therapeutics.
March 26, 2024
·
3 min read
Pharm Country
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives-Adenosine clinical development paused
Portage Biotech Inc. today reported that it is expanding its evaluation of strategic alternatives and implementing additional measures to extend its available cash runway.
April 12, 2024
·
3 min read
Drug Development
Portage Biotech Reports Business and Strategic Update
Portage Biotech Inc. today announced the outcome from the company’s comprehensive review of its pipeline in the context of the current capital raising market conditions.
January 4, 2024
·
4 min read
Business
Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update
Portage Biotech Inc., a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, reported financial results for the fiscal quarter ended December 31, 2023.
February 28, 2024
·
12 min read
Press Releases
Portage Biotech Announces 1-for-20 Reverse Stock Split
August 13, 2024
·
4 min read
1 of 18,219
Next
